AG
FLNA

Advisor Group’s Filana Therapeutics FLNA Stock Holding History

Advisor Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Buy
624
+300
+93% +$518 ﹤0.01% 4772
2019
Q3 		$0 Hold
324
– – ﹤0.01% 5401
2019
Q2 		$0 Buy
324
+287
+776% +$325 ﹤0.01% 5343
2019
Q1 		$0 Hold
37
– – ﹤0.01% 5312
2018
Q4 		$0 Hold
37
– – ﹤0.01% 5214
2018
Q3 		$0 Sell
37
-300
-89% -$456 ﹤0.01% 5203
2018
Q2 		$1K Hold
337
– – ﹤0.01% 4824
2018
Q1 		$2K Sell
337
-500
-60% -$3.38K ﹤0.01% 4710
2017
Q4 		$3K Buy
837
+200
+31% +$808 ﹤0.01% 4586
2017
Q3 		$2K Buy
637
+371
+139% +$1.33K ﹤0.01% 4567
2017
Q2 		$1K Buy
266
+16
+6% +$76 ﹤0.01% 4666
2017
Q1 		$1K Buy
250
+229
+1,090% +$1.04K ﹤0.01% 4570
2016
Q4 		$0 Hold
21
– – ﹤0.01% 4603
2016
Q3 		$0 Hold
21
– – ﹤0.01% 4595
2016
Q2 		$0 Buy
+21
New +$333 ﹤0.01% 4483

Other funds holding FLNA

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Advisor Group's FLNA Position: Q4 2019 in Review

Advisor Group increased its Filana Therapeutics (FLNA) stake by 93% in Q4 2019, buying an estimated $518 and bringing the position to 624 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4772.

Advisor Group first reported a position in FLNA in Q2 2016 and has held it in 15 quarters since. 31 funds tracked by Wall St. Rank hold FLNA as of Q4 2019.

  • Advisor Group held 624 shares of Filana Therapeutics worth $4K as of Q4 2019.
  • Advisor Group bought 300 Filana Therapeutics shares in Q4 2019, an estimated $518.
  • Filana Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4772 holding.
  • Advisor Group first reported a position in Filana Therapeutics in Q2 2016 and has held it in 15 quarters since.
  • 31 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.